E-LIB Suche - Ergebnisse für: Cantley, Gordon

1

National document-handling systems for science and technolo..

Information sciences series

Carter, Launor Franklin ; Cantley, Gordon ; Rowell, John T.... , 1967

2

PROTACs Targeting BRM (SMARCA2) Afford Selective In Vivo De..:

Berlin, Michael ; Cantley, Jennifer ; Bookbinder, Mark...
Journal of Medicinal Chemistry. 67 (2024) 2 - p. 1262-1313 , 2024

Link: https://doi.org/10.1021/..

3

Welfare Assessment and Husbandry Practices of Working Horse..:

Fröhlich, Navina ; Sells, Patrick D. ; Sommerville, Rebecca...
Animals. 10 (2020) 3 - p. 392 , 2020

Link: https://doi.org/10.3390/..

4

A Preexistent Hypoxic Gene Signature Predicts Impaired Isle..:

Cantley, James ; Walters, Stacey N. ; Jung, Min-Ho...
Cell Transplantation. 22 (2013) 11 - p. 2147-2159 , 2013

Link: https://doi.org/10.3727/..

5

Hadron and electron response in a uranium liquid argon calo..:

Aronson, S. ; Gordon, H. ; Guryn, W....
Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment. 269 (1988) 3 - p. 492-506 , 1988

Link: https://doi.org/10.1016/..

6

A phase II study of MK-2206, an AKT inhibitor, in uterine s..:

Stover, Elizabeth H. ; Xiong, Niya ; Myers, Andrea P....
Gynecologic Oncology Reports. 40 (2022) - p. 100974 , 2022

Link: https://doi.org/10.1016/..

7

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K in..:

Garrido-Castro, Ana C. ; Saura, Cristina ; Barroso-Sousa, Romualdo...
Breast Cancer Research. 22 (2020) 1 - p. , 2020

Link: https://doi.org/10.1186/..

8

Results of an abbreviated phase II study of AKT inhibitor M..:

Lee, Elizabeth K. ; Tan-Wasielewski, Zhenying ; Aghajanian, Carol...
Gynecologic Oncology Reports. 32 (2020) - p. 100546 , 2020

Link: https://doi.org/10.1016/..

9

Phase II, 2‐stage, 2‐arm, PIK3CA mutation stratified trial ..:

Myers, Andrea P. ; Konstantinopoulos, Panagiotis A. ; Barry, William T....
International Journal of Cancer. 147 (2019) 2 - p. 413-422 , 2019

Link: https://doi.org/10.1002/..

10

Phase II trial of AKT inhibitor MK-2206 in patients with ad..:

Xing, Yan ; Lin, Nancy U. ; Maurer, Matthew A....
Breast Cancer Research. 21 (2019) 1 - p. , 2019

Link: https://doi.org/10.1186/..

11

PTEN loss is a context‐dependent outcome determinant in obe..:

Westin, Shannon N. ; Ju, Zhenlin ; Broaddus, Russell R....
Molecular Oncology. 9 (2015) 8 - p. 1694-1703 , 2015

Link: https://doi.org/10.1016/..

12

PKM2 Isoform-Specific Deletion Reveals a Differential Requi..:

Israelsen, William J. ; Dayton, Talya L. ; Davidson, Shawn M....
Cell. 155 (2013) 2 - p. 397-409 , 2013

Link: https://doi.org/10.1016/..

13

Somatic Mutations of PIK3R1 Promote Gliomagenesis:

Quayle, Steven N. ; Lee, Jennifer Y. ; Cheung, Lydia W T....
PLoS ONE. 7 (2012) 11 - p. e49466 , 2012

Link: https://doi.org/10.1371/..

14

Specificity of LIM Domain Interactions with Receptor Tyrosi..:

Wu, Rui-yun ; Durick, Kyle ; Songyang, Zhou...
Journal of Biological Chemistry. 271 (1996) 27 - p. 15934-15941 , 1996

Link: https://doi.org/10.1074/..

15

Welfare Assessment and Husbandry Practices of Working Horse..:

Fröhlich, Navina ; Sells, Patrick D ; Sommerville, Rebecca...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142562/. , 2020

Link: http://www.ncbi.nlm.nih...